Semaglutide stimulates GLP-1 receptors to increase insulin secretion in response to meals, suppress glucagon, and slow gastric emptying, while tirzepatide adds GIP receptor action that further reduces appetite and body weight
Growth is supported by advances in oral peptide absorption technologies and increasing patient preference for needle free therapies
You said there is some FDA oversight here
From there, Eden connects you with licensed healthcare providers who review your health history, goals, and current medications to determine whether a GLP-1 medication (if any) is appropriate for you
By following a structured process of assessment, lab work, and professional monitoring, you can safely access the medications needed to support a healthier life